Watson Pharmaceuticals, Inc. to Present at Wachovia’s 19th Annual Mid-Year Equity Conference

CORONA, CA--(Marketwire - June 18, 2009) -

Watson Pharmaceuticals, Inc. (NYSE: WPI), a leading specialty pharmaceutical company, announced today that Paul Bisaro, Watson’s president and chief executive officer, will provide an overview and update of the Company’s business at Wachovia’s 19th Annual Mid-Year Equity Conference on Tuesday, June 23, 2009 at 2:30 p.m. Eastern Daylight Time.

This presentation will be webcast live and can be accessed on Watson Pharmaceuticals’ Investor Relations Web site at http://ir.watson.com. The webcast can also be accessed at the following URL:

http://www.wsw.com/webcast/wa55/wpi

An archived version will be available for 30 days after the live presentation and can be accessed at the same locations.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a global leader in the development and distribution of pharmaceuticals with a broad portfolio of generic products and a specialized portfolio of brand pharmaceuticals focused on Urology, Women’s Health and Nephrology/Medical.

For press releases and other company information, visit Watson Pharmaceuticals’ Web site at http://www.watson.com.